Ultragenyx Pharmaceu (RARE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RARE | VERA | NUVB | ||
| Company | Ultragenyx Pharmaceu | Vera Therapeutics Inc Cl A | Nuvation Bio Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | ||
| Open | 19.32 | 53.26 | 9.25 | ||
| High | 20.49 | 53.76 | 9.44 | ||
| Low | 18.41 | 51.46 | 8.89 | ||
| Latest | 19.72 | 52.25 | 9.06 | ||
| Change | -14.47 | -1.33 | -0.34 | ||
| % Change | -42.32% | -2.48% | -3.62% | ||
| Volume | 21,671,301 | 1,363,200 | 6,940,315 | ||
| 20-Day Average Volume | 2,518,845 | 1,818,685 | 6,159,625 | ||
| Previous Close | 34.19 | 53.58 | 9.40 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 34.24 | 47.15 | 8.63 | ||
| 20-Day Raw Stochastic | 6.10% | 83.75% | 69.93% | ||
| 20-Day Relative Strength | 24.02 | 70.38 | 65.72 | ||
| Weighted Alpha | -31.73 | +60.72 | +199.07 | ||
| Today's Opinion | 8% Sell | 100% Buy | 100% Buy | ||
| Previous Opinion | 64% Buy | 100% Buy | 100% Buy | ||
| Last Month's Opinion | 16% Buy | 88% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -41.13% since 12/19/25 | +2.01% since 12/19/25 | -4.03% since 12/19/25 | ||
| Low | 18.41 on 12/29/25 | 51.16 on 12/22/25 | 8.89 on 12/29/25 | ||
| High | 35.12 on 12/22/25 | 56.05 on 12/24/25 | 9.75 on 12/22/25 | ||
| 1-Month | |||||
| %Chg | -43.25% since 11/28/25 | +54.81% since 11/28/25 | +12.83% since 11/28/25 | ||
| Low | 18.41 on 12/29/25 | 32.66 on 12/01/25 | 7.45 on 12/02/25 | ||
| High | 39.89 on 12/08/25 | 56.05 on 12/24/25 | 9.75 on 12/22/25 | ||
| 3-Month | |||||
| %Chg | -35.05% since 09/29/25 | +80.80% since 09/29/25 | +181.37% since 09/29/25 | ||
| Low | 18.41 on 12/29/25 | 23.05 on 11/06/25 | 3.31 on 09/30/25 | ||
| High | 39.89 on 12/08/25 | 56.05 on 12/24/25 | 9.75 on 12/22/25 | ||
| 6-Month | |||||
| %Chg | -46.00% since 06/27/25 | +130.68% since 06/27/25 | +369.43% since 06/27/25 | ||
| Low | 18.41 on 12/29/25 | 19.07 on 08/07/25 | 1.87 on 07/01/25 | ||
| High | 42.37 on 07/09/25 | 56.05 on 12/24/25 | 9.75 on 12/22/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,298,582 | 3,425,263 | 3,222,630 | ||
| Shares Outstanding, K | 96,478 | 63,928 | 342,833 | ||
| Annual Sales | 560,230,000 | 0 | 7,870,000 | ||
| Annual Net Income | -569,180,000 | -152,150,000 | -567,940,000 | ||
| Last Quarter Sales | 159,930,000 | 0 | 13,120,000 | ||
| Last Quarter Net Income | -180,410,000 | -80,290,000 | -55,790,000 | ||
| 60-Month Beta | 0.16 | 1.21 | 1.58 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.81 on 11/04/25 | -1.26 on 11/05/25 | -0.16 on 11/03/25 | ||
| Latest Earnings Date | 02/12/26 | 02/25/26 | 03/05/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||